To validate pharmacological COX-2/PGE2 blockade specifically targets the iDAMP without affecting immunostimulatory DAMPs, we treated murine G69 and Panc02 cancer cells with gemcitabine ± celecoxib in vitro. The gene discussed is PTGS2; the disease is cancer.